Pacer Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26M | Buy |
|
|||||
|
2025
Q2 | $17.8M | Buy |
|
|||||
|
2025
Q1 | $14.9M | Sell |
|
|||||
|
2024
Q4 | $15.6M | Buy |
|
|||||
|
2024
Q3 | $15.1M | Sell |
|
|||||
|
2024
Q2 | $18M | Buy |
|
|||||
|
2024
Q1 | $15.6M | Sell |
|
|||||
|
2023
Q4 | $16.8M | Buy |
|
|||||
|
2023
Q3 | $10.2M | Buy |
|
|||||
|
2023
Q2 | $9.08M | Sell |
|
|||||
|
2023
Q1 | $11.8M | Buy |
|
|||||
|
2022
Q4 | $4.23M | Buy |
|
|||||
|
2022
Q3 | $2.96M | Buy |
|
|||||
|
2022
Q2 | $2.86M | Sell |
|
|||||
|
2022
Q1 | $3.41M | Sell |
|
|||||
|
2021
Q4 | $4.71M | Sell |
|
|||||
|
2021
Q3 | $5.24M | Buy |
|
|||||
|
2021
Q2 | $5.43M | Buy |
|
|||||
|
2021
Q1 | $5.18M | Sell |
|
|||||
|
2020
Q4 | $6.2M | Sell |
|
|||||
|
2020
Q3 | $10.5M | Sell |
|
|||||
|
2020
Q2 | $12.7M | Buy |
|
|||||
|
2020
Q1 | $5.64M | Buy |
|
|||||
|
2019
Q4 | $4.43M | Sell |
|
|||||
|
2019
Q3 | $7.94M | Buy |
|
|||||
|
2019
Q2 | $7.56M | Buy |
|
|||||
|
2019
Q1 | $6.83M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $4.83M | Buy |
|
|||||
|
2018
Q2 | $3.4M | Buy |
|
|||||
|
2018
Q1 | $2.68M | Buy |
|
|||||
|
2017
Q4 | $2.13M | Buy |
|
|||||
|
2017
Q3 | $1.27M | Buy |
|
|||||
|
2017
Q2 | $929K | Buy |
|
|||||
|
2017
Q1 | $725K | Buy |
|
|||||
|
2016
Q4 | $466K | Sell |
|
|||||
|
2016
Q3 | $600K | Sell |
|
|||||
|
2016
Q2 | $616K | Sell |
|
|||||
|
2016
Q1 | $570K | Buy |
|
|||||
|
2015
Q4 | $871K | Buy |
|